mRNA vaccine

FACT FOCUS: RFK Jr.’s reasons for cutting mRNA vaccine not supported by evidence

by Melissa Goldin edited by Andrew Zinin Health and Human Services Secretary Robert F. Kennedy Jr. speaks during an event where President Donald Trump will sign an executive order restarting the Presidential Fitness Test in public schools, Thursday, July 31, 2025, in the Roosevelt Room of the White House in Washington. Credit: AP Photo/Jacquelyn Martin Although […]

FACT FOCUS: RFK Jr.’s reasons for cutting mRNA vaccine not supported by evidence Read More »

Health secretary RFK Jr. shuts door on U.S. investment in mRNA vaccine research

By Helen Branswell Health Secretary Robert F. Kennedy Jr. on Tuesday announced that the government’s emergency preparedness agency will no longer fund work on messenger RNA vaccines, delivering a crippling blow to the country’s capacity to develop vaccines during the next pandemic or public health emergency. Kennedy said the Biomedical Advanced Research and Development Authority

Health secretary RFK Jr. shuts door on U.S. investment in mRNA vaccine research Read More »

Less pain, more gain: Phenol-groups drive a new recipe for safer, stronger mRNA vaccines

by University of Pennsylvania edited by Stephanie Baum, reviewed by Andrew Zinin  Penn Engineering researchers Emily Han and Dongyoon Kim, from left. Credit: Bella Ciervo As millions of people know firsthand, the most common side effect of mRNA vaccines like the COVID-19 shot is inflammation: soreness, redness and a day or two of malaise. But what if mRNA

Less pain, more gain: Phenol-groups drive a new recipe for safer, stronger mRNA vaccines Read More »

mRNA vaccines modified to include cytokine IL-12 enhance T cell response

by University of Pennsylvania edited by Sadie Harley, reviewed by Robert Egan   Credit: CC0 Public Domain In the quest to design vaccines that better help the body’s immune system fight disease, scientists are always looking for more tools for their arsenal. The strong antibody responses generated by vaccines provide an important first round of defense, but “you

mRNA vaccines modified to include cytokine IL-12 enhance T cell response Read More »

New mRNA vaccine is more effective and less costly to develop, study finds

by University of Pittsburgh edited by Sadie Harley, reviewed by Robert Egan   Credit: Unsplash/CC0 Public Domain A new type of mRNA vaccine is more scalable and adaptable to continuously evolving viruses such as SARS-CoV-2 and H5N1, according to a study by researchers at the University of Pittsburgh School of Public Health and the Pennsylvania State University. The

New mRNA vaccine is more effective and less costly to develop, study finds Read More »

Scroll to Top